Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ETON
#2570
Eton Pharmaceutcials, Inc. Common Stock
16.9
9
-0.93%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-0.93%
Aylık değişim
+13.04%
6 aylık değişim
-2.80%
Yıllık değişim
+13.12%
Önceki kapanış
17.1
5
Open
16.9
9
Bid
Ask
Low
16.9
9
High
16.9
9
Hacim
47
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ETON
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
25.84 M
26.82 M
26.82 M
26.82 M
26.82 M
—
Valuation ratios
Enterprise value
134.76 M
342.27 M
330.67 M
356.77 M
545.62 M
1.58 B
Price to earnings ratio
-27.53
-90.22
-71.49
-90.37
-87.73
-339.82
Price to sales ratio
0.02
8.84
7.04
6.49
8.26
30.62
Price to cash flow ratio
-0.06
355.96
61.44
31.08
27.46
475.94
Price to book ratio
0.01
14.12
4.34
4.24
6.03
28.72
Enterprise value to EBITDA ratio
-38.2
-1 000.8
182.09
70.96
90.26
-657.49
Profitability ratios
Return on assets %
0.02
-0.01
0.02
0.03
0.02
0.05
Return on equity %
0.04
-0.03
0.06
0.11
0.08
0.23
Return on invested capital %
14.59
-20.59
3.55
10.92
9.77
3.64
Gross margin %
61.04
55.6
57.06
63
34.97
210.63
Operating margin %
4.93
-14.14
2.72
7.79
6.07
2.44
EBITDA margin %
7.85
24.06
4.84
3.06
8.13
40.09
Net margin %
6.07
-5.63
9.1
13.66
8.58
25.7
Liquidity ratios
Quick ratio
1.41
1.29
1.43
1.16
1.25
5.13
Current ratio
1.51
2.06
1.97
1.77
1.63
7.43
Inventory turnover
2.01
0.6
0.51
0.37
0.72
2.21
Asset turnover
0.31
0.21
0.22
0.2
0.22
0.85
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.12
0.39
0.36
0.27
0.26
1.28
Long term debt to total equity ratio
0.26
1.22
1.23
1.14
1.19
4.78
Per share metrics
Operating cash flow per share
0.02
-0.03
0.08
0.3
0.45
0.79
EBIT per share
0.02
0.02
-0.02
-0.05
-0.05
-0.1
EBITDA per share
0.03
0.11
0.03
0.02
0.07
0.23
Total debt per share
—
—
—
—
—
—
Cash per share
0.76
0.58
0.65
0.94
1.38
3.55
Net current asset value per share
1.12
1.58
1.86
2.55
2.68
8.66
Tangible book value per share
0.38
-0.4
-0.35
-0.33
-0.33
-1.41
Working capital per share
0.38
0.81
0.92
1.11
1.03
3.87
Book value per share
0.6
0.94
0.91
0.89
0.86
3.6
Haberler
DESMODA oral solüsyonu diabetes insipidus için FDA onayı aldı
DESMODA oral solution receives FDA approval for diabetes insipidus
Eton Pharmaceuticals hisseleri ultra nadir hastalık ilacının lisanslanmasıyla yükseldi
Eton Pharmaceuticals stock rises after licensing ultra-rare disease drug
Eton Pharmaceuticals ultra nadir hastalık tedavi adayı için lisans aldı
Eton Pharmaceuticals licenses ultra-rare disease treatment candidate
Implied Volatility Surging for Eton Pharmaceuticals Stock Options
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates
Eton Pharmaceuticals kazancı $0,07 ile beklentilere göre daha kötü, kâr ise beklentilere göre yüksek
Eton Pharmaceuticals earnings missed by $0.07, revenue topped estimates
Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday
Eton Stock Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold